Total Assets - Eliem Therapeutics Inc (NASDAQ:ELYM) - Alpha Spread

Eliem Therapeutics Inc
NASDAQ:ELYM

Watchlist Manager
Eliem Therapeutics Inc Logo
Eliem Therapeutics Inc
NASDAQ:ELYM
Watchlist
Price: 8.43 USD 1.81% Market Closed
Market Cap: 563m USD
Have any thoughts about
Eliem Therapeutics Inc?
Write Note

Eliem Therapeutics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eliem Therapeutics Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Eliem Therapeutics Inc
NASDAQ:ELYM
Total Assets
$110.5m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Assets
$141.9B
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$53.6B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$20.1B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$36.1B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Eliem Therapeutics Inc's Total Assets?
Total Assets
110.5m USD

Based on the financial report for Dec 31, 2023, Eliem Therapeutics Inc's Total Assets amounts to 110.5m USD.

What is Eliem Therapeutics Inc's Total Assets growth rate?
Total Assets CAGR 3Y
65%

Over the last year, the Total Assets growth was -18%. The average annual Total Assets growth rates for Eliem Therapeutics Inc have been 65% over the past three years .

Back to Top